18:47 , Nov 13, 2018 |  BC Innovations  |  Distillery Techniques

Assays and screens

TECHNOLOGY: Cell-free assay; diagnostic assays A nanopore-based system for quantifying metabolites in bodily fluids could be used to develop point-of-care diagnostics for multiple diseases, including stroke, Parkinson’s disease (PD) and insulin resistance. The method involves...
07:00 , Apr 23, 2012 |  BC Week In Review  |  Clinical News

ActoGeniX preclinical data

In a mouse model of Type I diabetes, ActoGeniX's oral ActoBiotic for Type I diabetes plus low-dose systemic anti-CD3 mAbs stably reverted overt autoimmune diabetes in a significantly greater proportion of mice at 14 weeks...